Title:
PHARMACEUTICAL COMPOSITION FOR TREATING PARKINSON'S DISEASE AND INHIBITING SIDE EFFECTS OF LEVODOPA, CONTAINING MELANIN CONCENTRATING HORMONE AS ACTIVE INGREDIENT
Document Type and Number:
WIPO Patent Application WO/2017/014545
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition and a health functional food for treating Parkinson's disease or inhibiting the side effects of levodopa, containing a melanin concentrating hormone as an active ingredient. The composition of the present invention, containing a melanin concentrating hormone as an active ingredient, recovers the loss of dopaminergic nerve cells, thereby having an excellent effect in treating and preventing Parkinson's disease, and alleviating dyskinesia induced by levodopa.
Inventors:
PARK HI JOON (KR)
JEON SONG HEE (KR)
KIM JONG PIL (KR)
JEON SONG HEE (KR)
KIM JONG PIL (KR)
Application Number:
PCT/KR2016/007884
Publication Date:
January 26, 2017
Filing Date:
July 20, 2016
Export Citation:
Assignee:
DONGGUK UNIV INDUSTRY-ACADEMIC COOP FOUND (KR)
UNIV-INDUSTRY COOP GROUP OF KYUNG HEE UNIV (KR)
UNIV-INDUSTRY COOP GROUP OF KYUNG HEE UNIV (KR)
International Classes:
A61K38/22; A61K31/198
Foreign References:
| US5210076A | 1993-05-11 | |||
| KR20150017763A | 2015-02-17 | |||
| KR20100088136A | 2010-08-06 | |||
| US20030031707A1 | 2003-02-13 |
Other References:
THANVI ET AL.: "Levodopa-induced Dyskinesia in Parkinson's Disease: Clinical Features, Pathogenesis, Prevention and Treatment", POSTGRADUATE MEDICAL JOURNAL, vol. 83, 2007, pages 384 - 388, XP055348991
LEE: "A Novel Target for L-dopa Induced Dyskinesia in Parkinson's Disease: the Role of Melanin Concentrating Hormone", MASTER'S THESIS OF KYUNGHEE UNIVERSITY, February 2016 (2016-02-01)
LEE: "A Novel Target for L-dopa Induced Dyskinesia in Parkinson's Disease: the Role of Melanin Concentrating Hormone", MASTER'S THESIS OF KYUNGHEE UNIVERSITY, February 2016 (2016-02-01)
Attorney, Agent or Firm:
SON, Min (KR)
Download PDF: